KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Long-Term Debt Issuances: 2016-2025

Historic Long-Term Debt Issuances for BeOne Medicines (ONC) over the last 3 years, with Sep 2025 value amounting to $885.0 million.

  • BeOne Medicines' Long-Term Debt Issuances was N/A to $885.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $916.6 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is 59.77% down from last year.
  • BeOne Medicines' Long-Term Debt Issuances amounted to $885.0 million in Q3 2025, which was up 9,675.76% from $9.1 million recorded in Q1 2024.
  • In the past 5 years, BeOne Medicines' Long-Term Debt Issuances ranged from a high of $885.0 million in Q3 2025 and a low of $155,000 during Q2 2021.
  • In the last 3 years, BeOne Medicines' Long-Term Debt Issuances had a median value of $12.4 million in 2023 and averaged $229.1 million.
  • Per our database at Business Quant, BeOne Medicines' Long-Term Debt Issuances tumbled by 99.69% in 2021 and then surged by 520.90% in 2022.
  • BeOne Medicines' Long-Term Debt Issuances (Quarterly) stood at $6.0 million in 2021, then soared by 520.90% to $37.4 million in 2022, then crashed by 81.99% to $6.7 million in 2023, then reached $9.1 million in 2024, then reached $885.0 million in 2025.
  • Its Long-Term Debt Issuances stands at $885.0 million for Q3 2025, versus $9.1 million for Q1 2024 and $6.7 million for Q3 2023.